共 76 条
[1]
Kumar N(2016)Global incidence of primary malignant bone tumors Curr Orthop Pract 27 530-534
[2]
Gupta B(2017)NCCN guidelines insights: bone cancer, version 2.2017 J Natl Comp Cancer Netw 15 155-167
[3]
Biermann JS(2010)18F-FDG-PET and PET/CT for evaluating primary bone tumors Pet Clin 5 327-339
[4]
Chow W(2018)Applications of PET/CT and PET/MR imaging in primary bone malignancies PET Clin 13 623-634
[5]
Reed DR(2014)PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions Semin Musculoskelet Radiol 18 133-148
[6]
Mittra E(2020)Review. Total-body PET/CT: current applications and future perspectives Am J Roentgenol 215 325-337
[7]
Iagaru A(2009)Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions Skeletal Radiol 38 451-458
[8]
Behzadi AH(2010)PET/CT in primary musculoskeletal tumours: a step forward Eur Radiol 20 2959-2972
[9]
Raza SI(2021)Quantitative FDG PET assessment for oncology therapy Cancers (Basel) 13 869-2161
[10]
Carrino JA(2008)Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry J Clin Oncol Off J Am Soc Clin Oncol 26 2155-13